Changes in SLIT2 expression are associated with the migration of human ovarian clear cell carcinoma cells

Lin,Cuei-Jyuan; Huang,Way-Ren; Wu,Chia-Zhen; Tseng,Ruo-Chia

doi:10.3892/ol.2021.12812

Changes in SLIT2 expression are associated with the migration of human ovarian clear cell carcinoma cells

Authors:
- Cuei-Jyuan Lin
- Way-Ren Huang
- Chia-Zhen Wu
- Ruo-Chia Tseng
View Affiliations

Affiliations: Department of Laboratory Medicine, Keelung Chang Gung Memorial Hospital, Keelung 20401, Taiwan, R.O.C., GLORIA Operation Center, National Tsing Hua University, Hsinchu 30013, Taiwan, R.O.C., Department of Molecular Biology and Human Genetics, Tzu Chi University, Hualien 97004, Taiwan, R.O.C.
Published online on: May 24, 2021 https://doi.org/10.3892/ol.2021.12812
Article Number: 551
Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ovarian clear cell carcinoma (OCCC) is characterized by a poor survival of patients, which is mainly due to metastasis and treatment failure. Slit guidance ligand 2 (SLIT2), a secreted protein, has been reported to modulate the migration of neural cells and human cancer cells. However, the effect of changes in SLIT2 expression on the regulation of cell migration in OCCC remains unknown. The present study examined alterations in SLIT2 expression using OCCC cell models, including low‑ and high‑mobility SKOV3 cells, as well as OCCC tissues. DNA methylation analysis suggested that promoter hypermethylation was responsible for the low expression levels of SLIT2 in OCCC cells. The demethylating agent 5‑Aza‑deoxycytosine was able to restore SLIT2 expression at both the mRNA and protein levels in high‑mobility SKOV3 cells that harbored the relevant methylated promoter. Overexpression of SLIT2 inhibited the migration of high‑mobility OCCC cells, as well as decreased the protein expression levels of β‑catenin, phosphorylated (p)AKT and snail family transcriptional repressor 1 (SNAI1). On the other hand, knockdown of SLIT2 increased the migration of low‑mobility OCCC cells, and enhanced the protein expression levels of β‑catenin, pAKT and SNAI1. Overall, the results of the present study provided evidence that low expression levels of SLIT2 were associated with increased OCCC cell migration, and that SLIT2 may act as a suppressor gene of cancer cell migration.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
2	Website of Health Promotion Administration, Ministry of Health and Welfare, Taiwan, . 2019.https://www.hpa.gov.tw/Pages/ashx/File.ashx?FilePath=~/File/Attach/10227/File_11644.pdf
3	Tan DS, Miller RE and Kaye SB: New perspectives on molecular targeted therapy in ovarian clear cell carcinoma. Br J Cancer. 108:1553–1559. 2013. View Article : Google Scholar : PubMed/NCBI
4	Shaw TJ, Senterman MK, Dawson K, Crane CA and Vanderhyden BC: Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer. Mol Ther. 10:1032–1042. 2004. View Article : Google Scholar : PubMed/NCBI
5	Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A and Siegel RL: Ovarian cancer statistics, 2018. CA Cancer J Clin. 68:284–296. 2018. View Article : Google Scholar : PubMed/NCBI
6	Seyfried TN and Huysentruyt LC: On the origin of cancer metastasis. Crit Rev Oncog. 18:43–73. 2013. View Article : Google Scholar : PubMed/NCBI
7	Okamoto A: Management and new strategy of ovarian clear cell carcinoma. Int J Clin Oncol. 25:4182020. View Article : Google Scholar : PubMed/NCBI
8	Chaffer CL and Weinberg RA: A perspective on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
9	Jiang L, Wang Y, Rong Y, Xu L, Chu Y, Zhang Y and Yao Y: MiR-1179 promotes cell invasion through SLIT2/ROBO1 axis in esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 8:319–327. 2015.PubMed/NCBI
10	Tseng RC, Chang JM, Chen JH, Huang WR, Tang YA, Kuo IY, Yan JJ, Lai WW and Wang YC: Deregulation of SLIT2-mediated Cdc42 activity is associated with esophageal cancer metastasis and poor prognosis. J Thorac Oncol. 10:189–198. 2015. View Article : Google Scholar : PubMed/NCBI
11	Jiang Z, Liang G, Xiao Y, Qin T, Chen X, Wu E, Ma Q and Wang Z: Targeting the SLIT/ROBO pathway in tumor progression: Molecular mechanisms and therapeutic perspectives. Ther Adv Med Oncol. 11:17588359198552382019. View Article : Google Scholar : PubMed/NCBI
12	Lucas B and Hardin J: Mind the (sr)GAP-roles of Slit-Robo GAPs in neurons, brains and beyond. J Cell Sci. 130:3965–3974. 2017.PubMed/NCBI
13	Blockus H and Chédotal A: Slit-Robo signaling. Development. 143:3037–3044. 2016. View Article : Google Scholar : PubMed/NCBI
14	Qiu H, Zhu J, Yu J, Pu H and Dong R: SLIT2 is epigenetically silenced in ovarian cancers and suppresses growth when activated. Asian Pac J Cancer Prev. 12:791–795. 2011.PubMed/NCBI
15	Dai CF, Jiang YZ, Li Y, Wang K, Liu PS, Patankar MS and Zheng J: Expression and roles of Slit/Robo in human ovarian cancer. Histochem Cell Biol. 135:475–485. 2011. View Article : Google Scholar : PubMed/NCBI
16	Dong R, Yu J, Pu H, Zhang Z and Xu X: Frequent SLIT2 promoter methylation in the serum of patients with ovarian cancer. J Int Med Res. 40:681–686. 2012. View Article : Google Scholar : PubMed/NCBI
17	Dickinson RE and Duncan WC: The SLIT-ROBO pathway: A regulator of cell function with implications for the reproductive system. Reproduction. 139:697–704. 2010. View Article : Google Scholar : PubMed/NCBI
18	Sirohi VK, Popli P, Sankhwar P, Kaushal JB, Gupta K, Manohar M and Dwivedi A: Curcumin exhibits anti-tumor effect and attenuates cellular migration via Slit-2 mediated down-regulation of SDF-1 and CXCR4 in endometrial adenocarcinoma cells. J Nutr Biochem. 44:60–70. 2017. View Article : Google Scholar : PubMed/NCBI
19	Chang PH, Hwang-Verslues WW, Chang YC, Chen CC, Hsiao M, Jeng YM, Chang KJ, Lee EY, Shew JY and Lee WH: Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/β-catenin pathway. J Cancer Res. 72:4652–4661. 2012. View Article : Google Scholar : PubMed/NCBI
20	Yeh YM, Chuang CM, Chao KC and Wang LH: MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α. Int J Cancer. 133:867–878. 2013. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
22	Marchini S, Mariani P, Chiorino G, Marrazzo E, Bonomi R, Fruscio R, Clivio L, Garbi A, Torri V, Cinquini M, et al: Analysis of gene expression in early-stage ovarian cancer. Clin Cancer Res. 14:7850–7860. 2008. View Article : Google Scholar : PubMed/NCBI
23	Makii C, Oda K, Sone K, Sone K, Hasegawa K, Uehara Y, Nishijima A, Asada K, Koso T, Fukuda T, et al: MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53. Oncotarget. 7:75328–75338. 2016. View Article : Google Scholar : PubMed/NCBI
24	Yamaguchi K, Huang Z, Matsumura N, Mandai M, Okamoto T, Baba T, Konishi I, Berchuck A and Murphy SK: Epigenetic determinants of ovarian clear cell carcinoma biology. Int J Cancer. 135:585–597. 2014. View Article : Google Scholar : PubMed/NCBI
25	Kang J, Shin SH, Yoon H, Huh J, Shin HW, Chun YS and Park JW: FIH is an oxygen sensor in ovarian cancer for G9a/GLP-Driven epigenetic regulation of metastasis-related genes. Cancer Res. 78:1184–1199. 2018. View Article : Google Scholar : PubMed/NCBI
26	Chang JM, Tsai AC, Huang WR and Tseng RC: The alteration of CTNNBIP1 in lung cancer. Int J Mol Sci. 20:56842019. View Article : Google Scholar : PubMed/NCBI
27	Lamouille S, Xu J and Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
28	Puisieux A, Brabletz T and Caramel J: Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol. 16:488–494. 2014. View Article : Google Scholar : PubMed/NCBI
29	Wang LH, Wu CF, Rajasekaran N and Shin YK: Loss of tumor suppressor gene function in human cancer: An overview. Cell Physiol Biochem. 51:2647–2693. 2018. View Article : Google Scholar : PubMed/NCBI
30	Dickinson RE, Myers M and Duncan WC: Novel regulated expression of the SLIT/ROBO pathway in the ovary: Possible role during luteolysis in women. Endocrinology. 149:5024–5034. 2008. View Article : Google Scholar : PubMed/NCBI
31	Dickinson RE, Fegan KS, Ren X, Hillier SG and Duncan WC: Glucocorticoid regulation of SLIT/ROBO tumour suppressor genes in the ovarian surface epithelium and ovarian cancer cells. PLoS One. 6:e277922011. View Article : Google Scholar : PubMed/NCBI
32	Jeon MJ, Lim S, You MH, Park Y, Song DE, Sim S, Kim TY, Shong YK, Kim WB and Kim WG: The role of Slit2 as a tumor suppressor in thyroid cancer. Mol Cell Endocrinol. 483:87–96. 2019. View Article : Google Scholar : PubMed/NCBI
33	Göhrig A, Detjen KM, Hilfenhaus G, Körner JL, Welzel M, Arsenic R, Schmuck R, Bahra M, Wu JY, Wiedenmann B and Fischer C: Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer. Cancer Res. 74:1529–1540. 2014. View Article : Google Scholar
34	Tseng RC, Lee SH, Hsu HS, Chen BH, Tsai WC, Tzao C and Wang YC: SLIT2 attenuation during lung cancer progression deregulates beta-catenin and E-cadherin and associates with poor prognosis. Cancer Res. 70:543–551. 2010. View Article : Google Scholar : PubMed/NCBI
35	Vergara D, Merlot B, Lucot JP, Collinet P, Vinatier D, Fournier I and Salzet M: Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett. 291:59–66. 2010. View Article : Google Scholar : PubMed/NCBI
36	Stella MC, Trusolino L and Comoglio PM: The Slit/Robo system suppresses hepatocyte growth factor-dependent invasion and morphogenesis. Mol Biol Cell. 20:642–657. 2009. View Article : Google Scholar : PubMed/NCBI